相关实验视频

Updated: Jul 6, 2025

In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein

In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein

Published on: January 2, 2015

陶酸化中的温度诱导的人工物:对可靠的阿尔茨海默氏病研究的影响

Geoffrey Canet^1,2, Emma Rocaboy¹, Francis Laliberté²

¹Department of Psychiatry and Neurosciences, Faculty of Medicine, Laval University, Québec G1V 4G2, Canada.

Experimental neurobiology

|January 10, 2024

概括

在临床前模型中,温度变化迅速影响的酸化. 在安乐死前迅速冷却细胞,避免麻醉,对于精确的阿尔茨海默病患者至关重要.

科学领域:

神经科学是一个神经科学.
生物化学生物化学

背景情况:

酸化是阿尔茨海默病和病研究中的关键标记物.
陶酸化对温度波动敏感,影响实验准确性.
由于温度变化而发生的酸化变化的速度在很大程度上是未知的.

研究的目的:

在神经元细胞系和小鼠中,研究 fosforylation 的动力学,以应对神经元细胞系的温度变化.
为了确定在实验过程中快速变化的温度对陶酸化的影响.

主要方法:

在从化器转移到室温时,检查了N2a和SH-SY5Y神经元细胞系中的陶酸化.
在接受异花麻醉的小鼠中评估了的酸化.
在放置在冰上的细胞中的酸化变化与化后的室温变化进行比较.

主要成果:

在将细胞培养物从37°C移动到室温后几秒钟内发生了显著的陶酸化变化.
在化后立即放置在冰中的细胞显示了最小的酸化变化.
在小鼠的异氨酸麻醉中,在几秒钟内迅速诱导的高酸化.

结论:

温度变化,即使是短暂的变化,也会迅速改变的酸化水平.
实验方案必须严格控制温度,以确保可靠的 fosforylation 数据.
建议包括立即冷却细胞,避免安乐死前麻醉.

关键词:

阿尔茨海默氏症是阿尔茨海默氏症的一种疾病.麻醉麻醉是一种麻醉.在C57BL6小鼠中.神经元细胞是一种神经元细胞.的酸化是的酸化.温度温度是指温度.

更多相关视频

Assay for Phosphorylation and Microtubule Binding Along with Localization of Tau Protein in Colorectal Cancer Cells

Assay for Phosphorylation and Microtubule Binding Along with Localization of Tau Protein in Colorectal Cancer Cells

Published on: October 10, 2017

Nuclear Magnetic Resonance Spectroscopy for the Identification of Multiple Phosphorylations of Intrinsically Disordered Proteins

Nuclear Magnetic Resonance Spectroscopy for the Identification of Multiple Phosphorylations of Intrinsically Disordered Proteins

Published on: December 27, 2016

相关概念视频

Alzheimer's Disease: Overview

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...

Alzheimer's Disease: Treatment

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...